SCHEMBL8395343

SCHEMBL8395343

CCCCOc1ccccc1NC([NH])=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.66
POLB P06746 2/20 0.61
TSHR P16473 2/20 0.61
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
MAPT P10636 3/20 0.53
GAA P10253 2/20 0.53
ALDH1A1 P00352 2/20 0.53
LMNA P02545 2/20 0.53
HTT P42858 2/20 0.53
PKM P14618 1/20 0.53
NLRP1 Q9C000 1/20 0.53
KDM4E B2RXH2 3/20 0.52
MEN1 O00255 1/20 0.52
ALOX15 P16050 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
PTPN1 P18031 3/20 0.51
EBP Q15125 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
GPR55 Q9Y2T6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8930340 0.94 KMT2A (0.59) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL6838359 0.86 KMT2A (0.68) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL7956544 0.86 KMT2A (0.72) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL8396602 0.84 KMT2A (0.58) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL7956543 0.84 KMT2A (0.66) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL12667254 0.84 KMT2A (0.73) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL10782336 0.81 KMT2A (0.58) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL248401 0.81 KMT2A (0.66) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL18554186 0.81 KMT2A (0.62) KMT2APOLBTSHRNPC1RAB9A
SCHEMBL11644679 0.81 GAA (0.64) KMT2APOLBTSHRMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5864043-A CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST KARL THOMAE GMBH (DE) 1999-01-26 US disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed